Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness?
Juliusson
G
G
D000740:Anemia / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001803:Blood Transfusion; D002835:Christianity; D017338:Cladribine / Q000009:adverse effects*; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000209:etiology*; D016312:Treatment Refusal
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D017338:Cladribine